Fifty-seven patient advocacy organizations have collectively urged Congress to block a proposed rule from the Trump administration's Office of Management and Budget (OMB). The rule, scheduled to take effect October 1, would significantly alter federal financial assistance regulations, granting the President and political appointees unprecedented power over research funding decisions. Organizations like the American Diabetes Association and Susan G. Komen expressed grave concerns that this could undermine scientific research, cede global leadership to countries like China, and place funding decisions in the hands of political appointees rather than scientific experts. AI
RANK_REASON The cluster concerns a significant policy change proposed by a federal agency that has broad implications for scientific research funding, with a large number of advocacy groups actively campaigning against it. [lever_c_demoted from significant: ic=1 ai=0.4]
- American Diabetes Association
- American Heart Association
- American Lung Association
- Blood Cancer United
- Cancer Nation
- Chuck Schumer
- Colorectal Cancer Alliance
- Donald Trump
- Friends of Cancer Research
- Hakeem Jeffries
- John Thune
- Mike Johnson
- Office of Management and Budget
- Pancreatic Cancer Action Network
- Susan G. Komen
- Trump administration
- United for Cures
- United States Congress
- UsAgainstAlzheimer’s
- ZERO Prostate Cancer
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
